California’s Proposition 65, The Safe Drinking Water and Toxic Enforcement Act, as amended, requires businesses to inform individuals of potential exposure to certain chemicals identified by the State of California that may cause cancer, birth defects or reproductive effects.
Medtronic has identified its products that are in scope of Proposition 65 disclosure requirements. Please select the “SEE LIST” button under the relevant business therapy to access the list of affected products. Note: The lists are updated on the last day of each month.
Medtronic considers patient safety and customer satisfaction its top priorities. View terms of use.
Minimally Invasive Therapies
Surgical solutions; gastrointestinal products; renal care; airway and ventilation products; lung solutions; patient monitoring and informatics systems
Cardiac and Vascular
Products designed to treat heart rhythm disorders, heart failure, coronary artery disease, heart valve disease, aortic disease, and peripheral vascular disease
Diabetes
Integrated diabetes management solutions, including insulin pump therapy, continuous glucose monitoring, and therapy management systems
Restorative Therapies
Medical devices and implants used to treat spine and musculoskeletal systems, neurological and neurovascular disorders and diseases, and surgical technologies to improve neuro and spine procedures including navigation, imaging, and robotics
